IRMD
Iradimed Co
85.20$
-1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.6% | 13.0% | 16.5% | 24.2% | 28.9% | 14.8% | 24.2% | 26.6% | 18.3% | 26.9% | 18.8% | 20.5% | 35.0% | 29.8% | |
| 1.4% | 1.2% | 1.0% | 0.7% | 0.8% | 5.7% | 3.6% | 3.2% | 4.2% | 3.4% | 1.3% | 1.2% | 1.1% | 1.4% | |
| 2.3% | 2.4% | 4.6% | 3.9% | 5.7% | 10.6% | 5.8% | 4.8% | 12.5% | 3.5% | 2.6% | 3.3% | 3.4% | 3.5% | |
| – | – | 4.0% | -1.3% | 2.6% | 10.3% | 5.8% | 3.4% | 13.5% | 5.0% | 3.0% | – | – | – | |
| 3.4% | -7.7% | -2.6% | 0.9% | 1.6% | -4.9% | -5.9% | -5.1% | -3.7% | -3.8% | -9.5% | -9.0% | 5.1% | -5.2% | |
| 2.1% | 1.7% | 3.9% | 1.0% | 4.7% | 3.6% | 0.9% | 1.3% | 2.0% | 1.8% | 3.5% | 12.2% | 10.9% | 9.3% | |
| -2.2% | -1.7% | -53.0% | -0.2% | -6.0% | -4.4% | 5.0% | 8.3% | 0.8% | 1.6% | -2.6% | -12.2% | -12.0% | -10.0% | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | – | 32.6% | 39.6% | 30.0% | 23.6% | 20.2% | 18.7% | 17.9% | |
| – | – | 80.2% | 1.9% | -30.7% | -7.9% | -1.0% | -1.2% | -3.8% | -1.4% | 0.3% | -0.9% | – | – | |
| – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -3.1% | -4.5% | 81.2% | 7.4% | -28.1% | -8.2% | 3.1% | 5.2% | 1.6% | 0.1% | -23.8% | -20.8% | -19.6% | -21.0% | |
| 14.4% | 6.7% | 44.7% | 31.4% | -5.1% | 2.1% | 32.3% | 40.1% | 20.8% | 28.5% | -7.6% | -12.5% | 3.4% | -1.3% | |
| 17.5% | 11.3% | 12.6% | 23.2% | 24.3% | 11.2% | 23.4% | 25.3% | 16.3% | 25.2% | 15.3% | 8.3% | 24.1% | 20.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.